Brown Vaginal Discharge After Unprotected Sex
For a woman presenting with brown vaginal discharge after unprotected sex, empiric treatment should cover the most common sexually transmitted infections (STIs) and bacterial vaginosis (BV), particularly if follow-up is uncertain or if she meets high-risk criteria (age <25 years, new or multiple partners). 1
Initial Clinical Assessment
Key History and Physical Findings to Evaluate
- Discharge characteristics: Brown discharge may represent old blood mixed with vaginal secretions, which can occur with cervicitis, BV, or trichomoniasis 1
- Vaginal pH testing: pH >4.5 suggests BV or trichomoniasis rather than candidiasis 1
- Whiff test: Fishy odor with KOH application indicates BV or trichomoniasis 1
- Microscopy findings: Look for clue cells (BV), motile trichomonads, or inflammatory cells suggesting cervicitis 1
- Risk assessment: Unprotected sex is a key risk factor for STIs including chlamydia, gonorrhea, and trichomoniasis 1
Recommended Treatment Approach
Empiric Treatment Regimen (Preferred When Follow-up Uncertain)
The CDC recommends empiric coverage for the most common post-sexual exposure infections when follow-up cannot be ensured: 1
- Ceftriaxone 125 mg IM single dose (covers gonorrhea) 1
- Azithromycin 1 g orally single dose OR Doxycycline 100 mg orally twice daily for 7 days (covers chlamydia) 1
- Metronidazole 2 g orally single dose (covers trichomoniasis and BV) 1, 2
Alternative Approach If Follow-up Is Assured
If the patient can reliably return for results and you can perform diagnostic testing:
- Obtain nucleic acid amplification testing (NAAT) for chlamydia and gonorrhea 1, 3
- Perform wet mount microscopy for trichomonads and clue cells 1
- Measure vaginal pH and perform whiff test 1
- Treat based on confirmed diagnoses rather than empirically 1, 4
Specific Treatment by Confirmed Diagnosis
If Bacterial Vaginosis Confirmed (pH >4.5, clue cells, fishy odor)
- Metronidazole 500 mg orally twice daily for 7 days (95% cure rate) 1, 5, 2
- Alternative: Metronidazole 2 g orally single dose (84% cure rate, useful when compliance is a concern) 1, 2
- Advise patient to avoid alcohol during treatment and for 24 hours after due to disulfiram-like reaction 1, 2
If Trichomoniasis Confirmed (motile trichomonads on wet mount or positive NAAT)
- Metronidazole 2 g orally single dose 2, 4
- Treat sexual partner(s) simultaneously to prevent reinfection 2, 4
If Chlamydia or Gonorrhea Confirmed
- Chlamydia: Azithromycin 1 g orally single dose OR Doxycycline 100 mg orally twice daily for 7 days 1
- Gonorrhea: Ceftriaxone 125 mg IM single dose 1
- Partner notification and treatment is essential 1
Critical Clinical Considerations
When Empiric Treatment Is Most Appropriate
- Patient age <25 years with new or multiple sexual partners 1
- Uncertain follow-up or poor compliance anticipated 1
- High local prevalence of STIs (>5% gonorrhea prevalence) 1
- Patient anxiety about potential STI exposure warrants reassurance through treatment 1
Common Pitfalls to Avoid
- Failing to treat empirically when follow-up is uncertain: The most common STIs (trichomoniasis, chlamydia, gonorrhea, BV) account for the majority of post-sexual exposure vaginal discharge, and delayed treatment can lead to complications including pelvic inflammatory disease 1, 6
- Treating only for candidiasis: Brown discharge is rarely caused by yeast; candidiasis typically presents with white, thick discharge and normal pH (<4.5) 1, 4
- Neglecting partner treatment: For trichomoniasis and other STIs, failure to treat partners leads to reinfection 2, 4
- Not considering pregnancy: Perform pregnancy test before treatment; avoid doxycycline in pregnancy and use azithromycin instead 1
Emergency Contraception
- Offer emergency contraception if unprotected sex occurred within 120 hours 1
- Levonorgestrel 1.5 mg orally as single dose (both tablets at once) is preferred 1
- Perform baseline pregnancy test 1
Follow-Up Recommendations
- Return in 2 weeks if symptoms persist or if empiric treatment was not given initially 1
- Repeat testing for syphilis and HIV at 6-12 weeks if initial tests were negative and exposure risk was significant 1
- Test of cure is not routinely needed unless symptoms persist, pregnancy is present, or compliance is uncertain 1
- Counsel on condom use until partner treatment is completed 1